Teva Pharmaceutical Industries (NYSE:TEVA)

Short Sellers Grow More Selective on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Chico’s FAS, Southwestern Energy Drop into Wednesday’s 52-Week Low Club

May 24, 2017: Here are four stocks trading with relatively heavy volume among 106 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »

Alexion, Teva Plunge into Tuesday’s 52-Week Low Club

May 23, 2017: Here are four stocks trading with relatively heavy volume among 88 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »

Seadrill, Teva Pharmaceuticals Dip Into Monday’s 52-Week Low Club

May 22, 2017: Here are four stocks trading with relatively heavy volume among 79 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by more ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

Short Interest in Major Pharma Shrinks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Disney, Snap, Whole Foods and More Key Earnings Reports Coming This Week

24/7 Wall St. has put together a preview of a few major companies scheduled to report their quarterly results this coming week. The broad markets have been pushing closer to ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Express Scripts, Teva Pharmaceuticals Drop into Tuesday’s 52-Week Low Club

April 25, 2017: Here are four stocks trading with relatively heavy volume among 63 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »

Rite Aid, Valeant Tumble into Thursday’s 52-Week Low Club

April 20, 2017: Here are four stocks trading with relatively heavy volume among 54 equities making new 52-week lows in Thursday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »

Valeant, Arena Pharmaceuticals in Tuesday’s 52-Week Low Club

April 18, 2017: Here are four stocks trading with relatively heavy volume among 85 equities making new 52-week lows in Tuesday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »

Cenovus ¬†Energy, DryShips Dip into Wednesday’s 52-Week Low Club

April 12, 2017: Here are four stocks trading with relatively heavy volume among 51 equities making new 52-week lows in Wednesday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »